— Know what they know.
Not Investment Advice
Also trades as: SDZ.SW (SIX) · $vol 107M · 0SAN.L (LSE) · $vol 27M

SDZNY OTC

Sandoz Group AG
1W: +1.1% 1M: +10.8% 3M: +14.4% YTD: +31.5% 1Y: +52.6% 3Y: +223.3%
$96.00
-3.36 (-3.38%)
 
Weekly Expected Move ±3.5%
$90 $94 $97 $101 $104
OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Strong Buy · Power 70 · $41.5B mcap · 416M float · 0.0056% daily turnover · Short 33% of daily vol
Credit Risk of going bust: lower than 75% of companies Debt: 13.0% of company value Bonds: none of note held by US funds details ▾
If the stock fell to about $1.15 (down 99%), Sandoz Group AG would be worth roughly what it owes.
Total debt $6.20B against a stock market value of $41.54B.
Distance to default 8.62 (Merton model): prices to 2026-10-28, balance sheet 2026-06-30, debt counted $3.68B (short-term plus half of long-term), stock volatility 31.5%; Altman Z'' 2.56. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.

Income Trends

Revenue
$8.8B -14.9% ▼
5Y CAGR: -0.4%
Gross Profit
$4.2B -15.6% ▼
5Y CAGR: +0.0%
Operating Income
$1.4B +342.8% ▲
5Y CAGR: +0.3%
Net Income
$729M +72765.1% ▲
5Y CAGR: +10.9%
EPS (Diluted)
$1.67 +0.0% ▲
5Y CAGR: +10.6%
EBITDA
$1.4B +83.2% ▲
5Y CAGR: +0.8%

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
Revenue$8.8B$8.6B$10.0B$10.4B$8.8B
YoY Growth-2.7%-2.2%+16.0%+4.1%-14.9%
Cost of Revenue$4.6B$4.6B$5.4B$5.5B$4.7B
Gross Profit$4.2B$4.0B$4.6B$4.9B$4.2B
Gross Margin47.2%47.0%45.7%47.4%47.0%
R&D Expenses$833M$796M$926M$932M$837M
SG&A Expenses$1.9B$22K$2.4B$2.4B$2.0B
Operating Expenses$2.8B$2.9B$4.2B$4.6B$2.8B
Operating Income$1.4B$1.1B$375M$307M$1.4B
Operating Margin15.7%13.3%3.8%3.0%15.4%
Interest Expense$61M$84M$202M$251M$175M
Income Before Tax$1.2B$1.0B$130M-$11M$962M
Tax Expense$368M$233M$50M-$12M$234M
Net Income$830M$784M$77M$1M$729M
Net Margin9.4%9.1%0.8%0.0%8.2%
EPS (Diluted)$1.93$1.82$0.18$0.00$1.67
EBITDA$1.7B$1.5B$857M$742M$1.4B
Shares Outstanding431M431M431M431M437M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms